SASK LEARNING RESOURCES DISTBusiness Directories,Company Directories

Company Name: Corporate Name:	SASK LEARNING RESOURCES DIST
Company Title:
Company Description:
Keywords to Search:
Company Address:	1500 4th Ave,REGINA,SK,Canada
ZIP Code: Postal Code:	S4R8G8
Telephone Number:	3067875987
Fax Number:
Website:
Email:
USA SIC Code(Standard Industrial Classification Code):	9121-02
USA SIC Description:	Government Offices-Provincial
Number of Employees:	Unknown
Sales Amount:
Credit History: Credit Report:	Institution
Contact Person:
Remove my name

Company Directories & Business Directories

copy and paste this google map to your website or blog!

Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples:
WordPress Example, Blogger Example)

Input Form:Deal with this potential dealer,buyer,seller,supplier,manufacturer,exporter,importer

(Any information to deal,buy, sell, quote for products or service)

Previous company profile:
SASK LEGAL AID COMMISSION
SASK LANDS BRANCH
SASK LEADER OF THE OPPOSITION

Next company profile:
SASK LABOUR RELATIONS BOARD
SASK LABOUR RELATIONS BRANCH
SASK LABOUR RELATIONS BRANCH

Company News:

HD Chorea Medication Guide | INGREZZA® (valbenazine) capsules
View the medication guide of INGREZZA® (valbenazine) capsules for HD chorea See PI, including Boxed Warning, and Med Guide
Ingrezza: Uses, Dosage, Side Effects, Warnings - Drugs. com
Ingrezza (valbenazine) is used to treat tardive dyskinesia (TD) and chorea associated with Huntington's disease Ingrezza uses, side effects, doses, and more
Ingrezza for Chorea in Huntington’s Disease - HealthCentral
Ingrezza is approved for prescription to adults diagnosed with Huntington’s disease who experience chorea, uncontrollable movements associated with the condition
HD Chorea Efficacy | INGREZZA® (valbenazine) capsules | HCP
REFERENCES: INGREZZA [package insert] San Diego, CA: Neurocrine Biosciences, Inc Stimming EF, Claassen DO, Kayson E, et al Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington’s disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial Lancet Neurol 2023;22 (6):494-504 Data on file Neurocrine Biosciences, Inc Unified
Ingrezza now approved by FDA for chorea in Huntington’s disease
Chorea, characterized by uncontrolled, jerky movements that can affect any part of the body, affects as many as 90% of adults with Huntington’s “We are proud to bring Ingrezza to people living with HD [Huntington’s disease] and their caregivers who now have the option of a one-capsule, once-daily treatment that has demonstrated significant improvement in HD chorea in clinical studies
What is Huntington’s Chorea? | INGREZZA® (valbenazine) capsules
Learn more about Huntington’s disease (HD) and HD chorea, including the stages and common symptoms See PI, including Boxed Warning, and Med Guide
TD HD Chorea Dosing | INGREZZA® (valbenazine) capsules - HCP
Find the dosing options for once-daily INGREZZA treatment for tardive dyskinesia and Huntington’s disease chorea See Prescribing Info, including Boxed Warning
How Ingrezza Works for Tardive Dyskinesia and Chorea - WebMD
Ingrezza (in-GREH-zah) was approved in 2017 as the first medicine to help control movement in people with tardive dyskinesia and was approved for use in people with chorea caused by Huntington’s
How effective is Ingrezza? - Drugs. com
Ingrezza (valbenazine) is an oral medication that may be used to treat symptoms of tardive dyskinesia (TD) in adults It may also be used to treat adults with chorea associated with Huntington’s disease (HD), a hereditary progressive neurodegenerative disorder
Ingrezza (valbenazine) for Huntingtons disease | Huntingtons. . .
What is Ingrezza for Huntington’s disease? Ingrezza (valbenazine) is an oral medication approved in the U S to ease the involuntary, jerky movements known as chorea that are observed in most people with Huntington’s disease